Altman J, Oliveria SA, Christos PJ, Halpern AC. A survey of skin cancer screening in the primary care setting: a comparison with other cancer screening. Archives of Family Medicine. 2000;9:1022-1027.
[PubMed Abstract]
Amar D, Roistacher N, Rusch VW, Leung DHY, Ginsburg I, Zhang H, Bains MS, Downey RJ, Korst RJ, Ginsberg RJ. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic-surgery. Journal of Thoracic Surgery. 2000;120:790-798.
[PubMed Abstract]
Amar D, Fleisher M, Leung DHY, Zhang H, Ginsburg I, Roistach N. Perioperative alterations in plasma endothelin-1 and echocardiographic correlates of right heart function. Journal of Cardiotharoacic Vascular Anesthesia. 2000;14:140-143.
[PubMed Abstract]
Antonescu CR, Leung DH, Dudas M, Ladanyi M, Brennan M, Woodruff JM, Cordon-Cardo C. Alterations of cell-cycle regulators in localized synovial sarcoma - a multifactorial study with prognostic implications. American Journal of Pathology. 2000;156:977-983.
[PubMed Abstract]
Bach PB, Cramer LD, Begg CB, Warren JL: Racial-differences in the treatment of early-stage lung cancer - Reply (Letter). New England Journal of Medicine. 2000;342:518-519.
Bajorin DF, McCaffrey JA, Dodd PM, Hilton S, Mazumdar M, Kelly WK, Herr H, Scher HI, Icasiano E, Higgins G. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional-cell carcinoma of the urothelial tract B final report of a phase II trail evaluating 2 dosing schedules. Cancer 2000;88:1671-1678.
[PubMed Abstract]
Barakat RR, Gilewski TA, Almadrones L, Saigo PE, Venkatraman E, Hudis C, Hoskins WJ. Effect of adjuvant tamoxifen on the endometrium in women with breast-cancer B a prospective study using office endometrial biopsy. Journal of Clinical Oncology. 2000;18:3459-3463.
[PubMed Abstract]
Baron RH, Kelvin JF, Bookbinder M, Cramer L, Borgen PI, Thaler HT. Patients sensations after breast-cancer surgery - a pilot study. Cancer Practice. 2000;8:215-222.
Begg CB. Ruminations on the intent-to-treat principle. Controlled Clinical Trials. 2000;21:241-243.
[PubMed Abstract]
Begg CB. Cancer, genes and the environment (letter). New England Journal of Medicine. 2000;343:1495.
[PubMed Abstract]
Begg CB, Cramer LD, Venkatraman ES, Rosai J. Comparing tumor staging and grading systems: A case study and a review of the issues, using thymoma as a model. Statistics in Medicine. 2000;19:1997-2014.
[PubMed Abstract]
Begg CB, Leung DHY. On the use of surrogate endpoints in randomized trials (with discussion). Journal of the Royal Statistical Society. 2000;163:15-28.
Berwick M, Headley A, Fine J, Bolognia JL. Skin self-examination in patients at risk for the development of melanoma: I. Nurse education. Journal of Cancer Education. 2000;15:39-41.
Berwick M, Oliveria SA, Luo S, Headley A, Bolognia JL. A pilot study using nurse education as an intervention to increase skin self-examination for melanoma. Journal of Cancer Education. 2000;15:38-40.
[PubMed Abstract]
Berwick M. Gene-environment interactions in melanoma: current status and new investigational strategies. Forum (Genova) 2000;10:191-200.
[PubMed Abstract]
Berwick M. Patterns of sun exposure that are important in melanoma. In Newton-Bishop J, Dore J. Challenges in Melanoma. 2000 Blackwell Scientific Publishers, Oxford University (in press).
Berwick M, Vineis P. Review of human epidemiologic studies of DNA repair and cancer. Journal of the National Cancer Institute. 2000, 92:11-23.
Berwick M, Vineis P. Authors reply to letter re: Review of human epidemiologic studies of DNA repair and cancer. Journal of the National Cancer Institute. 2000;92.
Blute ML, Bergstralh EJ, Partin AW, Walsh PC, Kattan MW, Scardino PT, Montie JE, Pearson JD, Slezak JM, Zincke H. Validation of Partin Tables for predicting pathologic stage of clinically localized prostate cancer. Journal of Urology. 2000; 164(5):1591-1595.
[PubMed Abstract]
Blutt SE, Polek TC, Stewart LM, Kattan MW, Weigel NL. A calcitrol analog, EB1089, inhibits the growth of LNCaP Tumors in Nude Mice. Cancer Research. 2000; 60:779-782.
[PubMed Abstract]
Bowne WB, Antonescu CR, Leung DHY, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ. Dermatofibrosarcoma protuberans B A clinicopathological analysis of patients treated and followed at a single institution. Journal of Clinical Oncology. 2000;88:2711-2720.
[PubMed Abstract]
Brady MS, Oliveria SA, Christos PJ, Berwick M, Coit DG, Katz J, Halpern A. Patterns of detection in cutaneous melanoma-implications for secondary prevention. Cancer. 2000; 89:342-7.
[PubMed Abstract]
Busam KJ, Iversen K, Koplan KA, Old LJ, Berwick M, Spagnoli GC, Jungbluth AA. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma. Frequency of expression and correlation with prognostic parameters. Mod Pathology. 2000; 13:459-65.
[PubMed Abstract]
Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate-cancer cells in-vitro and in-vivo. Cancer Research. 2000;60:5165-5170.
[PubMed Abstract]
Camacho LH, Soignet SL, Chanel S, Ho R, Heller G, Scheinberg DA, Ellison R, Warrell RP. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. Journal of Clinical Oncology. 2000; 18: 2620-2625.
[PubMed Abstract]
Cantor SB, Kattan MW. Determining the area under the receiver operating characteristic curve for a binary diagnostic test. Medical Decision Making. 2000; 20(4):468-470.
[PubMed Abstract]
Cassileth BR, Vickers A. Cancer, unproven therapies and magic: the article reviewed. Oncology. 2000;14(9):1358-9.
Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The Memorial symptom assessment scale short form (MSAS-SF) Cancer. 2000; 89:1162-1171.
[PubMed Abstract]
Chapman PB, Morrisey D, Panageas KS, Williams L, Lewis JL, Dantis L, Houghton AN, Livingston PO. Vaccination with a bivalent GM2 and GD2 ganglioside vaccine: A trial comparing doses of GD2-KLH. Clinical Cancer Research. 2000; 12:4658-4662.
[PubMed Abstract]
Chapman PB, Morrissey DM, Panageas KS, Hamilton WB, Zhan C, Destro AN, Williams L, Israel RJ, Livingston PO. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-KLH+QS21 vaccine: a dose-response study. Clinical Cancer Research. 2000;6:874-879.
[PubMed Abstract]
Chi DS, Venkatraman ES, Masson V, Hoskins WJ. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecological Oncology. 2000;77:227-231.
[PubMed Abstract]
Christos PJ, Oliveria SA, Halpern AC, Fine JA, Barnhill RL, Berwick M. Signs and symptoms of melanoma in older populations. Journal of Clinical Epidemiology. 2000; 53:1044-1053.
[PubMed Abstract]
Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, Thaler HT, Polyak T, Rapkin B, Portenoy RK. The measurement of symptoms in children with cancer. Journal of Pain Symptoms Management. 2000; 19:363-377.
[PubMed Abstract]
Coogan PF, Rosenberg L, Palmer JR, Strom, BL, Zauber AG, Stolley PD, Shapiro S. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiology, Biomarkers and Prevention. 2000; 9:119-123.
[PubMed Abstract]
Coogan PF, Rosenberg L, Louik C, Zauber AG, Stolley PD, Strom BL, Shapiro S. NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease. Cancer Causes and Control. 2000; 11:249-255.
[PubMed Abstract]
D'Amico AV, Moul J, Kattan MW. Emerging prognostic factors for outcome prediction in clinically localized prostate cancer: prostate-specific antigen level, race, molecular markers, and neural networks. In Vogelzang NJ, Scardino PT, Shipley WU and Coffey DS, eds. Comprehensive Textbook of Genitourinary Oncology. Philadelphia: Lippincott Williams and Wilkins, 2000:680-700.
Dealava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardomin. FJ, Healey JH, Ladanyi M. Prognostic impact of p53 status in Ewing sarcoma. Cancer. 2000; 89:783-792.
Deckert PM, Jungbluth A, Montalto N, Clark MA, Finn RD, Williams Jr C, Richards EC, Panageas KS, Old LJ, Welt S. Pharmacokinetics and microdistribution of polyethylene glycolmodified humanized A33 antibody targeting to colon cancer xenografts. International Journal of Cancer. 2000; 87:382-390.
[PubMed Abstract]
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. 200 gastrointestinal stromal tumors - recurrence patterns and prognostic factors for survival. Annals of Surgery. 2000;231:51-58.
[PubMed Abstract]
Dodd PM, McCaffrey JA, Hilton S, Mazumdar M, Herr H, Kelly WK, Icasiano E, Boyle MG, Bajorin DF. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide plus paclitaxel plus cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract. Journal of Clinical Oncology. 2000; 18:840-846.
[PubMed Abstract]
Dodd PM, McCaffrey JA, Mazumdar M, Scher H, Higgins G, Boyle MG, Herr H, Bajorin DF. Evaluation of drug-delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer. Cancer Investigation.A120 2000;18:626-634.
[PubMed Abstract]
Dodd PM, McCaffrey JA, Mazumdar M, Icasiano E, Higgins G, Herr H, Bajorin DF. Phase II trial of PZA as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma. Investigational New Drugs. 2000; 18:247-251.
[PubMed Abstract]
Downey RJ, Rusch V, Hsu FI, Leon L, Venkatraman ES, Linehan D, Bains M, vanZee K, Korst R, Ginsberg R. Chest wall resection for locally recurrent breast cancer: is it worthwhile? Journal of Thoracic and Cardiovascular Surgery. 2000; 119:420-428.
[PubMed Abstract]
Donnelly GB. Glassman J. Long C. Torres P. Straus DJ. O'Brien JP. Bertino J. Moskowitz CH. Zelenetz AD. Portlock CS. Granulocyte-colony stimulating factor (G-CSF) may improve disease outcome in elderly patients with diffuse large cell lymphoma (DLCL) treated with CHOP chemotherapy. Leukemia & Lymphoma. 2000;39:67-75.
[PubMed Abstract]
Drobnjak M. Osman I. Scher HI. Fazzari M. Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clinical Cancer Research. 2000;6:1891-1895.
[PubMed Abstract]
Eastham JA, Kattan MW. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. Journal of Urology. 2000;163(1):143-5.
[PubMed Abstract]
Fazzari M. Heller G. Scher HI. The phase II/III transition. Toward the proof of efficacy in cancer clinical trials. Controlled Clinical Trials. 2000;21:360-368.
[PubMed Abstract]
Feinstein MB, Bach PB. Epidemiology of lung cancer. Chest Surg Clin N Am 2000;10:653-661.
[PubMed Abstract]
Foulkes WD, Satagopan JM, Chappuis PO, Wong N, Bigin LR, Boyd J, Offit K, Robson ME. The presence of a germ-line BRCA mutation is an independent poor-prognosis marker in breast cancer: a two-center historical cohort study. (Meeting abstract) American Journal of Human Genetics. 2000;67:379.
Gemignani ML, Cody HS, Fey JV, Tran KN, Venkatraman E, Borgen PI. Impact of sentinel lymph-node mapping on relative charges in patients with early-stage breast cancer. Annals of Surgery. 2000;7:575-580.
[PubMed Abstract]
Giesler RB, Cowen M, Miles BJ, Kattan MW. Assessing quality of life in men treated for localized prostate cancer: Development of a new instrument for use in multiple settings. Quality of Life Research. 2000;9:645-665.
[PubMed Abstract]
Gilewski T, Adluri S, Ragupathi G, Zhang SL, Yao TJ, Panageas K, Moynahan M, Houghton A, Norton L, Livingston PO. Vaccination of high-risk breast-cancer patients with mucin-1 (MUC1) keyhold limpet hemocyanin conjugate plus QS-21. Clinical Cancer Research. 2000; 6:1693-1701.
[PubMed Abstract]
Gonen M, Puri, M, Ruymgaart F, van Zuijlen M. The limiting density of unit-root test statistics: unknown mean, dependent errors. Journal of Time Series Analysis. 2000; 21:249-260.
Gonen M. A Bayesian analysis of intraclass correlations in the mixed linear model. Communications in Statistics: Theory and Methods. 2000; 29:1451-1464.
Gu M, Shi W, Huang J, Barakat RR, Thaler HT, Saigo PE. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer. 2000;90:143-147.
Gu M, Shi WJ, Barakat RR, Thaler HT, Saigo PE. Peritoneal washings in endometrial carcinoma - a study of 298 patients with histopathologic correlation. Acta Cytologica. 2000; 44:783-789.
[PubMed Abstract]
Guillem JG, Puig-La Calle JR, Akhurst T, Tickoo S, Ruo L, Minsky BD, Gollub MJ, Klimstra DS, Mazumdar M, Paty PB, Macapinlac H, Yeung H, Saltz L, Finn RD, Erdi Y, Humm J, Cohen AM, Larson S. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Diseases of the Colon & Rectum. 2000;43:18-24.
[PubMed Abstract]
Hann LE, Lui DM, Shi W, Bach AM, Selland DL, Castiel M. Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation. Radiology. 2000; 216:242-247.
[PubMed Abstract]
Herman CM, Wilcox GE, Kattan MW, Scardino PT, Wheeler TM. Lymphovascular invasion as a predictor of disease progression in prostate cancer. American Journal of Surgical Pathology. 2000; 24(6):859-863.
[PubMed Abstract]
Imbriaco M, Akhurst T, Hilton S, Yeung HWD, Macapinlac HA, Mazumdar M, Pace L, Kemeny N, Erdi Y, Cohen A, Fong Y, Guillem J, Larson SM. Whole-body FDG-PET in patients with recurrent colorectal carcinoma: a comparative study with CT. Clinical Positron Imaging. 2000;3:107-114.
[PubMed Abstract]
Jurcic JG. DeBlasio T. Dumont L. Yao TJ. Scheinberg DA. Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia. Clinical Cancer Research. 2000;6:372-380.
[PubMed Abstract]
Karadimitris A, Manavala JS, Thaler HT, Notaro R, Araten DJ, Nafa K, Roberts LAG, Weksler ME, Luzzatto L. Abnormal t-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood. 2000; 96: 2613-2620.
[PubMed Abstract]
Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Annals of Surgery. 2000;232:362-371.
[PubMed Abstract]
Kattan MW, Cooper RB. A simulation of factors affecting machine learning techniques: an examination of partitioning and class proportions. Omega International Journal of Management Science. 2000; 28:501-512.
Kattan MW, Beck JR, Miles BJ. Quantitative approaches to diagnostic testing and decision making in genitourinary oncology. In Vogelzang NJ, Scardino PT, Shipley WU and Coffey DS, eds. Comprehensive Textbook of Genitourinary Oncology. Philadelphia: Lippincott Williams and Wilkins, 2000:22-32.
Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. Journal of Clinical Oncology. 2000; 18(19):3252-3259.
[PubMed Abstract]
Kattan MW, Cooper RB. A simulation of factors affecting machine learning techniques: an examination of partitioning and class proportions. Omega International Journal of Management Science. 2000; 28:501-512.
Kattan MW, Fearn PA, Leibel S, Potters L. The definition of biochemical failure in patients treated with definitive radiotherapy. International Journal of Radiation Oncology. 2000; 48(5):1469-1474.
[PubMed Abstract]
Kewalramani T, Zelenetz AD, Hedrick EE, Donnelly G, Hunte S, Priovolos A, Qin J, Lyons NC, Yahalom J, Nimer SD, Moskowitz CH. High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-hodgkin's lymphoma: an intention-to-treat analysis. Blood. 2000;96:2399-2404.
[PubMed Abstract]
Knoblauch H, Muller-Myhsok B, Ben Avi L, Schuster H, Heath SC, Shipzen S, Aydin A, Reshef A, Eliav O, Lowe A, Schurr D, Friedlander Y, Luft FC, Leitersdorf L. Mapping a putative cholesterol-lowering gene on chromosome 13q by affected sib-pair linkage analysis. American Journal of Human Genetics. 2000;66:157-166.
[PubMed Abstract]
Kross RA, Ferri E, Leung D, Pratila M, Broad C, Veronesi M, Melendez JA. A comparative-study between a calcium-channel blocker (nicardipine) and a combined alpha-beta-blocker (labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesthesiology Annals. 2000; 91:904-909.
[PubMed Abstract]
Krug LM, Ng KK, Kris MG, Miller VA, Tong W, Heelan RT, Leon L, Leung D, Kelly J, Sirotnak FM. Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate. Clinical Cancer Research. 2000; 6:3493-3498.
[PubMed Abstract]
Kushner BH, Heller G, Kramer K, Cheung N-KV. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma. Cancer. 2000;89:2122-2130.
[PubMed Abstract]
La Calle J, Quayle J, Thaler HT, Shi W, Paty PB, Quan SHQ, Cohen AM, Guillem JG. Favorable short-term and long-term outcome after elective radical rectal cancer resection in patients 75 years of age or older. Diseases of the Colon & Rectum. 2000;43:1704-1709.
Lancaster T, Vickers AJ. Larger trials are needed (editorial). British Medical Journal BMJ 2000; 321: 476 Vickers AJ, Christos P. Bezwoda: evidence of fabrication in original paper (letter). Journal of Clinical Oncology. 2000;18:2933.
Lancaster T, Vickers AJ. Larger trials are needed. British Medical Journal. 2000; 321: 476.
Lee CT, Katz J, Shi WJ, Thaler HT, Reuter VE, Russo P. Surgical-management of renal tumors 4 cm. or less in a contemporary cohort. Journal of Urology. 2000;163:730-736.
[PubMed Abstract]
Levegrun S, Jackson A, Zelefsky MJ, Venkatraman ES, Skwarchuk MW, Schlegel W, Fuks Z, Leibel SA, Ling CC. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. International Journal of Radiation Oncology, 2000;47:1245-1260.
[PubMed Abstract]
Lewis JJ, Janetzki S, Schaed S, Panageas K, Wang S, Williams L, Meyers M, Butterworth L, Livingston PO, Chapman PB, Houghton AN. Evaluation of CD8+ T cell frequencies by the Elispot assay in healthy individuals and patients with metastatic melanoma immunized with tyrosinase peptide. International Journal of Cancer. 2000;87:391-398.
[PubMed Abstract]
Lewis JJ, Leung D, Espat J, Woodruff JM, Brennan MF. Effect of reresection in extremity soft-tissue sarcoma. Annals of Surgery. 2000;231:655-661.
[PubMed Abstract]
Liang KY, Qin J. Regression analysis under non-standard situations: a pairwise pseudo-likelihood approach. Journal of the Royal Statistical Society. 2000;62:773-786.
Linehan D, Lewis J, Leung D, Brennan M. Influence of biological factors and anatomic site in completely resected liposarcoma. Journal of Clinical Oncology. 2000;18:1637-1643.
[PubMed Abstract]
Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. Journal of Clinical Oncology. 2000;18:2728-2732.
[PubMed Abstract]
Makhija S, Sabbatini P, Aghajanian C, Venkatraman E, Spriggs DR, Barakat R. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian-cancer patients with a positive 2nd look. Gynecological Oncology. 2000;79:28-32.
[PubMed Abstract]
Martin J, Robitaille D, Perrault LP, Pellerin M, Page P, Searle N, Cartier R, Hebert Y, Pelletier LC, Thaler HT. Reinfusion of mediastinal blood after heart surgery. Journal of Thoracic Surgery. 2000;120:499-504.
[PubMed Abstract]
May C, Rivella S, Callegari J, Heller G, Gaensler KM, Luzzatto L, Sadelain M. Therapeutic hemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature. 2000;406:82-86.
[PubMed Abstract]
Mazumdar M, Smith A, Tong WP, Motzer RJ. Calvert's formula for dosing carboplatin: Overview and concerns of applicability in high-dose setting. Journal of the National Cancer Institute. 2000;92:1434-1436.
[PubMed Abstract]
Mazumdar M, Glassman JR. Categorizing a prognostic variable: Review of methods, code for easy implementation and applications to decision-making about cancer treatments. Statistics in Medicine. 2000;19:113-132.
[PubMed Abstract]
Miller LA, Singer ME, Swanson GP, Schrag D, Kuntz KM, Garber JE, Weeks JC. Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations. Journal of the American Medical Association. 2000;283:3070.
[PubMed Abstract]
Mora J, Cheung NK, Kushner BH, LaQuaglia MP, Kramer K, Fazzari M, Heller G, Chen L, Gerald WL. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. Journal of Molecular Diagnostics. 2000;2:37-46.
[PubMed Abstract]
Mora J, Filippa DA, Thaler HT, Polyak T, Cranor ML, Wollner N. Large-cell non-hodgkin-lymphoma of childhood - analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center. Cancer. 2000;88:186-197.
[PubMed Abstract]
Motzer RJ, Mazumdar M, Bacik J, Russo P, Berg WJ, Metz EM. Effect of cytokine therapy on survival for patients with advanced renal-cell carcinoma. Journal of Clinical Oncology. 2000;18:1928-1935.
[PubMed Abstract]
Motzer RJ, Sheinfeld J, Mazumdar M, Bains M, Mariani T, Bacik J, Bajorin D, Bosl GJ. Paclitaxel, ifosfamide, and cisplatin 2nd line therapy for patients with relapsed testicular germ-cell cancer. Journal of Clinical Oncology. 2000;18:2413-2418.
[PubMed Abstract]
Motzer RJ, Murphy BA, Bacik J, Schwartz LH, Nanus DM, Mariani T, Loehrer P, Wilding G, Fairclough DL, Cella D, Mazumdar M. Phase III trial of interferon alpha-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. Journal of Clinical Oncology. 2000;18:2972-2980.
[PubMed Abstract]
Motzer RJ, Mazumdar M, Sheinfeld J, Bajorin DF, Macapinlac HA, Bains M, Reich L, Flombaum C, Mariani T, Tong WP, Bosl GJ. Sequential dose-intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide salvage therapy for germ-cell tumor patients. Journal of Clinical Oncology. 2000;18:1173-1180.
[PubMed Abstract]
Olson SH, Mignone L, Harlap S. Selection of control groups using a commercial database and random digit dialing. American Journal of Epidemiology. 2000;152:585-592.
[PubMed Abstract]
Olson JD, Riedel E, DeAngelis LM. Long term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 2000;54:1442-1448.
[PubMed Abstract]
OReilly E, Hammond L, Donehower R, Schwartz G, Kelvin J, Aird S, Sharma S, Schrag D, Molloy K, Dejager R. A Phase II study of exatecan mesylate (DX-8951F) in advanced pancreatic cancer (Meeting Abstract). Annals of Oncology. 2000;11:0277.
Orjuela M, Ponce Castaneda V, Ridaura C, Lecona E, Leal C, Abramson DH, Orlow I, Gerald W, Cordon-Cardo C. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clinical Cancer Research. 2000;6:4010-4016.
[PubMed Abstract]
Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L, Zauber A, Trambert R, O'Sullivan ME, Russo P. Cigarette smoking patterns in patients after treatment of bladder cancer. Journal of Cancer Education. 2000;15:86-90.
[PubMed Abstract]
Papadakis V, Dunkel IJ, Cramer LD, Kramer E, Papadopoulos E, Goldman S, Packer RJ, Willoughby M, Baker D, Garvin J, Strandjord S, Coccia P, Kaplan AM, Klemperer M, Finlay JL. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Bone Marrow Transplantation. 2000;26:153-60.
[PubMed Abstract]
Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid. 2000;10:261-268.
[PubMed Abstract]
Puig-LaCalle J, Quayle J, Thaler HT, Shi W, Paty PB, Quan SH, Cohen AM, Guillem JG. Favorable short-term and long-term outcome after elective radical rectal cancer resection in patients 75 years of age or older. Diseases of the Colon & Rectum. 2000;43:1704-1709.
Qin J. Combining parametric and empirical likelihoods. Biometrika. 2000;87:484-490.
Rabbani F, Stapleton AMF, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. Journal of Urology. 2000; 164(6):1929-1934.
[PubMed Abstract]
Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C. Prevalence of complementary therapy use by women with breast cancer. a population-based survey. European Journal of Cancer. 2000;36(11):1359-64.
Rusch VW, Parekh KR, Leon L, Venkatraman E, Bains MS, Downey RJ, Boland P, Bilsky M, Ginsberg RJ. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. Journal of Thoracic Surgery. 2000;119:1147-1153.
[PubMed Abstract]
Scher HI, Heller G. Clinical states in prostate cancer - toward a dynamic-model of disease progression. Urology. 2000;55:323-327.
[PubMed Abstract]
Schrag D, Kuntz KM, Garber JE, Weeks JC. The impact of cancer prevention strategies on survival for women with breast cancer and BRCA1/2 mutations. Journal of the American Medical Association. 2000; 283: 617-624
[PubMed Abstract]
Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB. The influence of hospital procedure volume on outcomes following surgery for colon cancer. Journal of the American Medical Association. 2000;284:3028-3035.
[PubMed Abstract]
Shariat SF, Bergamaschi F, Adler HL, Nguyen C, Kattan MW, Wheeler TM, Slawin KM. Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy. Urology. 2000; 56:423-429.
[PubMed Abstract]
Sharma S, Gonen M. "Fluoropyrimidine chemotherapy improves 1-year mortality in people with stage IV or unresectable colorectal cancer compared with supportive care" Journal of Evidence-Based Oncology. 2000;1:116.
Skwarchuk MW, Jackson A, Zelefsky MJ, Venkatraman ES, Cowen DM, Levegrun S, Burman CM, Fuks Z, Leibel SA, Ling CC. Late rectal toxicity after conformal radiotherapy of prostate-cancer (I) - multivariate-analysis and dose-response. International Journal of Radiation Oncology. 2000;47:103-113.
[PubMed Abstract]
Slawin KM, Kattan MW, Scher HI, Scardino PT. Prostate-specific antigen in screening, prognosis of the primary tumor and monitoring of recurrent disease. In Perry MC, ed. 2000 Spring Educational Book. Alexandria: ASCO. 2000:596-608.
Slawin KM, Shariat SF, Nguyen C, Leventis AK, Weitao S, Kattan MW, Young CYF, Tindall DJ, Wheeler TM. Detection of metastatic prostate cancer using a spline variant-specific RT-PCR assay for human glandular Kallikrein. Cancer Research. 2000;60(24):7142-8.
[PubMed Abstract]
Smith AJ, Lewis JJ, Merchant NB, Leung DHY, Woodruff JM, Brennan MF. Surgical-management of intraabdominal desmoid tumors. British Journal of Surgery. 2000;87:608-613.
[PubMed Abstract]
Smith AJ, Nissan A, Lanouette NM, Shi WJ, Guillem JG, Wong WD, Thaler H, Cohen AM. Prokinetic effect of erythromycin after colorectal surgery - randomized, placebo-controlled, double-blind study. Diseases of the Colon & Rectum. 2000;43:333-337.
Smith AD, Satagopan JM, Gonen M. Some observations on identifying disease-related genes using expression data. (Meeting abstract) American Journal of Human Genetics. 2000;67:1423.
Sutton MA, Freund CT, Berkman SA, Dang TD, Kattan MW, Wheeler TM, Rowley DR, Lerner SP. In vivo Adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. Mol Ther 2000 2(3):211-217.
[PubMed Abstract]
Syngal S, Schrag D, Falchuk M, Tung N, Farraye F, Chung D, Wright M, Whetsell A, Miller G, Garber JE. Phenotypic characteristics associated with the APC gene 11807K mutation in Ashkenazi Jewish patients with colorectal polyps. Journal of the American Medical Association. 2000;284:857-860.
[PubMed Abstract]
Szijan I, Orlow I, Dalamon V, Vergani P, Danilowicz K, Mezzadri N, Cordon-Cardo C, Bruno O D. Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors. Oncol Rep.7:421-425, 2000.
[PubMed Abstract]
Tickoo SK, Pittas AG, Adler M, Fazzari M, Larson SM, Robbins RJ, Rosai J. Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates. Archives of Pathology & Laboratory Medicine. 2000;124:1440-1447.
[PubMed Abstract]
Usmani BA, Janeczko M, Shen R, Mazumdar M, Papandreou CN, Nanus DM. Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer. British Journal of Cancer. 2000;82:550-552.
[PubMed Abstract]
Vaughan TL, Stewart PA, Teschke K, Lynch CF, Swanson GM, Lyon JL, Berwick M. Occupational exposure to formaldehyde and wood dust and risk of nasopharyngeal carcinoma. Occupational and Environmental Medicine 2000;57:376-84.
[PubMed Abstract]
Venkatraman ES. Basic biostatistics. In: Handbook of Gynecologic Oncology, RR Barakat, MW Bevers, DM Gershenson and WJ Hoskins eds., Martin Dunitz. 2000, pp1-19.
Venkatraman ES. A permutation test to compare receiver operating characteristic curves. Biometrics. 2000;56:1134-1138.
[PubMed Abstract]
Vickers AJ. Use of hypericum as antidepressant: use of placebo in depression trial was unethical. British Medical Journal. 2000;320:1141.
Vickers A. The literature search for Bloom et al.'s review (letter). Int J Technol Assess Health Care 2000;16(3):944.
Vickers A. Researching complementary medicine. British Journal of Therapy and Rehabilitation 2000;7:26-9.
Vickers AJ, Smith C. Oscillococcinum in the prevention and treatment of influenza and influenza-like syndromes. (Cochrane Review) In: The Cochrane Library, Issue 1, 2000. Oxford: Update Software.
Vickers AJ. de Craen AJM. Why use placebos in clinical trials? A narrative review of the methodological literature. Journal of Clinical Epidemiology. 2000;53(2):157-161
[PubMed Abstract]
Vickers AJ. Clinical trials of homoeopathy and placebo: analysis of a scientific debate. Journal of Alternative and Complementary Medicine. 2000;6(1):49-56.
[PubMed Abstract]
Vickers AJ, van Haselen RA, Pang L, Berkovitz S. Inter-rater reliabilty of symptom repertorisation: a pragmatic empirical study. Br Hom J 2000;89:188-90
Vickers AJ, Smith C. Incorporating data from dissertations in systematic reviews. International Journal of Technology Assessment in Health Care. 2000;16(2):711-3.
[PubMed Abstract]
Vickers AJ. Why aromatherapy works (even if it doesn't) and why we need less research. British Journal of General Practice. 2000;50:444-5.
Vickers AJ, Christos P. Evidence of fabrication in original paper. Journal of Clinical Oncology. 2000;18(15):2933.
Vickers AJ. Recent advances in complementary medicine. British Medical Journal 2000:321(7262):683-6
Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, Yeung H, Macapinlac H, Rosai J, Robbins RJ. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. Journal of Clinical Endocrinology & Metabolism. 2000;85:1107-1113.
Wei G, Antonescu CR, Dealava E, Leung D, Huvos AG, Meyers PA, Healey JH, Ladanyi M. Prognostic impact of ink4a deletion in Ewing sarcoma. Cancer. 2000;89:793-799.
Weiser MR, Lewis JJ, Leung DHY, Brennan MF. Management of small, high-grade extremity soft-tissue sarcoma. Surgical Oncology. 2000;8:215-218.
Weiser RR, Downey RJ, Leung DHY, Brennan MF. Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. Journal of the American College of Surgeons. 2000;191:184-190.
Winawer SJ, Zauber AG. Colorectal cancer screening: now is the time. CMAJ 2000;163:543-544.
[PubMed Abstract]
Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, Hall D, Hamlin JA, Schapiro M, O'Brien MJ, Sternberg SS, Gottlieb LS, Hogan WJ, Khilani M, Ackroyd FW, Panish JF, Kussin L, Edelman M. Colonoscopy and double contrast barium enema for surveillance following polypectomy. New England Journal of Medicine. 2000; 342:1766-72.
[PubMed Abstract]
Yang K, Lamprecht SA, Liu YH, Shinozak H, Fan KH, Leung D, Newmark H, Steele VE, Kelloff GJ, Lipkin M. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane treated mouse colon. Carcinogene. 2000;21:1655-1660.
Yeung HWD, Macapinlac HA, Mazumdar M, Bains M, Finn RD, Larson SM. FDG-PET in esophageal cancer: incremental value over computed tomography. Clinical Positron Imaging. 2000; 2(5):255-60.
Zauber AG, Winawer SJ, Stewart ET. Comparison of Colonoscopy and Double-Contrast Barium Enema. New England Journal of Medicine. 2000;343:1729-30.
Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM, Hunt M, Wolfe T, Venkatraman ES, Jackson A, Skwarchuk M, Leibel SA. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiotherapy and Oncology. 2000;55:241-249.
[PubMed Abstract]
Zelefsky MJ, Yamada Y, Cohen G, Venkatraman ES, Fung AYC, Furhang E, Silvern D, Zaider M. Postimplantation dosimetric analysis of permanent transperineal prostate implantation B improved dose distributions with an intra operative computer optimized conformal planning technique. International Journal of Radiation Oncology. 2000;48:601-608.
[PubMed Abstract]
Zollman CE, Vickers AJ. ABC of complementary medicine. London: British Medical Journal Publishing. (2000).
Zupan B, Demsar J, Kattan MW, Beck JR, Bratko I. Machine learning for survival analysis: a case study on recurrence of prostate cancer. Artif Intell Med 2000; 20:59-75.
